Application of liquid biopsy as multi-functional biomarkers in head and neck cancer.
Journal
British journal of cancer
ISSN: 1532-1827
Titre abrégé: Br J Cancer
Pays: England
ID NLM: 0370635
Informations de publication
Date de publication:
02 2022
02 2022
Historique:
received:
22
07
2021
accepted:
01
11
2021
revised:
25
10
2021
pubmed:
9
12
2021
medline:
23
2
2022
entrez:
8
12
2021
Statut:
ppublish
Résumé
Head and neck squamous cell carcinoma (HNSCC) is a molecularly heterogeneous disease, with a 5-year survival rate that still hovers at ~60% despite recent advancements. The advanced stage upon diagnosis, limited success with effective targeted therapy and lack of reliable biomarkers are among the key factors underlying the marginally improved survival rates over the decades. Prevention, early detection and biomarker-driven treatment adaptation are crucial for timely interventions and improved clinical outcomes. Liquid biopsy, analysis of tumour-specific biomarkers circulating in bodily fluids, is a rapidly evolving field that may play a striking role in optimising patient care. In recent years, significant progress has been made towards advancing liquid biopsies for non-invasive early cancer detection, prognosis, treatment adaptation, monitoring of residual disease and surveillance of recurrence. While these emerging technologies have immense potential to improve patient survival, numerous methodological and biological limitations must be overcome before their implementation into clinical practice. This review outlines the current state of knowledge on various types of liquid biopsies in HNSCC, and their potential applications for diagnosis, prognosis, grading treatment response and post-treatment surveillance. It also discusses challenges associated with the clinical applicability of liquid biopsies and prospects of the optimised approaches in the management of HNSCC.
Identifiants
pubmed: 34876674
doi: 10.1038/s41416-021-01626-0
pii: 10.1038/s41416-021-01626-0
pmc: PMC8810877
doi:
Substances chimiques
Biomarkers, Tumor
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
361-370Subventions
Organisme : U.S. Department of Health & Human Services | National Institutes of Health (NIH)
ID : R01DE027809
Organisme : NIDCR NIH HHS
ID : R01 DE028674
Pays : United States
Organisme : U.S. Department of Health & Human Services | National Institutes of Health (NIH)
ID : R01DE028674
Organisme : NCI NIH HHS
ID : U01 CA230691
Pays : United States
Organisme : NIDCR NIH HHS
ID : R01 DE027809
Pays : United States
Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer Nature Limited.
Références
Oral Oncol. 2020 Mar;102:104558
pubmed: 32044652
ESMO Open. 2020 May;5(3):e000646
pubmed: 32414944
Cell Physiol Biochem. 2018;50(4):1429-1440
pubmed: 30355951
Technol Cancer Res Treat. 2021 Jan-Dec;20:1533033821990037
pubmed: 33641530
JAMA Otolaryngol Head Neck Surg. 2014 Sep;140(9):846-54
pubmed: 25078109
J Virol Methods. 2017 Aug;246:15-20
pubmed: 28414163
Int J Mol Sci. 2020 Nov 04;21(21):
pubmed: 33158181
Oral Oncol. 2008 Oct;44(10):915-9
pubmed: 18329326
Clin Lab. 2020 Jul 1;66(7):
pubmed: 32658437
Clin Cancer Res. 2019 Aug 1;25(15):4682-4690
pubmed: 31088830
Ann Oncol. 2014 Oct;25(10):2042-2047
pubmed: 25057171
Acta Otorhinolaryngol Ital. 2014 Oct;34(5):299-309
pubmed: 25709145
Nature. 2015 Jan 29;517(7536):576-82
pubmed: 25631445
Cells. 2020 Dec 31;10(1):
pubmed: 33396240
Clin Cancer Res. 2002 Jul;8(7):2260-5
pubmed: 12114429
Laryngoscope Investig Otolaryngol. 2020 Sep 01;5(5):868-878
pubmed: 33134534
Biomolecules. 2019 Apr 12;9(4):
pubmed: 31013839
Am J Surg. 1994 Nov;168(5):429-32
pubmed: 7977967
Clin Cancer Res. 2009 Jan 15;15(2):476-84
pubmed: 19147752
Science. 2011 Aug 26;333(6046):1157-60
pubmed: 21798893
Diagn Mol Pathol. 2009 Jun;18(2):81-7
pubmed: 19430297
Mitochondrion. 2015 Sep;24:113-21
pubmed: 26238294
Int J Cancer. 2020 Apr 15;146(8):2336-2347
pubmed: 31469434
Oncotarget. 2016 Jul 12;7(28):42988-42995
pubmed: 27119512
Cancer Lett. 2020 Dec 1;494:7-16
pubmed: 32781015
Head Neck. 2016 Apr;38 Suppl 1:E1666-73
pubmed: 26667883
Sci Rep. 2016 Aug 19;6:31520
pubmed: 27539254
Chin Clin Oncol. 2016 Apr;5(2):18
pubmed: 27121878
Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4331-5
pubmed: 17671113
Ann Oncol. 2019 Oct 1;30(10):1673
pubmed: 31168601
PeerJ. 2020 Jun 5;8:e9304
pubmed: 32547888
Proc Natl Acad Sci U S A. 2020 Jul 14;117(28):16167-16173
pubmed: 32601197
J Pers Med. 2021 Jun 17;11(6):
pubmed: 34204396
Oncoscience. 2018 Apr 29;5(3-4):75-87
pubmed: 29854876
BBA Clin. 2016 Dec 18;7:8-15
pubmed: 28053877
J Mater Chem B. 2019 Nov 21;7(43):6670-6704
pubmed: 31646316
Oncotarget. 2017 Jul 27;8(47):82459-82474
pubmed: 29137278
J Mol Diagn. 2020 Nov;22(11):1333-1343
pubmed: 32822851
Nat Commun. 2019 Jul 22;10(1):3256
pubmed: 31332191
Cancers (Basel). 2019 Mar 15;11(3):
pubmed: 30875950
Science. 2011 Aug 26;333(6046):1154-7
pubmed: 21798897
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Head Neck. 2015 Oct;37(10):1448-55
pubmed: 24844673
N Engl J Med. 2017 Aug 10;377(6):513-522
pubmed: 28792880
Cancers (Basel). 2020 Oct 15;12(10):
pubmed: 33076524
Cancer. 2013 Mar 1;119(5):963-70
pubmed: 23065693
Clin Invest Med. 2017 Feb 19;40(1):E1-E12
pubmed: 28218577
BMC Med Genomics. 2015 Jun 24;8:31
pubmed: 26104160
Cancer. 2021 May 15;127(10):1576-1589
pubmed: 33405231
Cancer Lett. 2020 Feb 28;471:49-60
pubmed: 31830557
J Clin Oncol. 2011 Nov 10;29(32):4294-301
pubmed: 21969503
BMC Cancer. 2017 May 16;17(1):333
pubmed: 28511705
Nat Rev Dis Primers. 2020 Nov 26;6(1):92
pubmed: 33243986
Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):e351-8
pubmed: 21985946
Nat Rev Cancer. 2011 Jan;11(1):9-22
pubmed: 21160525
Int J Cancer. 2018 Sep 1;143(5):1114-1127
pubmed: 29607493
Clin Transl Radiat Oncol. 2017 Feb 07;2:46-52
pubmed: 29658000
J Oral Pathol Med. 2020 Oct;49(9):842-848
pubmed: 32526815
Laryngoscope. 2017 Nov;127(11):E408-E414
pubmed: 28782189
Cancer Med. 2018 Dec;7(12):5910-5919
pubmed: 30565869
J Otolaryngol Head Neck Surg. 2017 Jan 14;46(1):5
pubmed: 28088212
J Extracell Vesicles. 2016 Mar 24;5:29289
pubmed: 27018366
Oral Oncol. 2019 Feb;89:34-39
pubmed: 30732956
Anticancer Res. 2020 Jun;40(6):3559-3564
pubmed: 32487658
PLoS One. 2018 Sep 7;13(9):e0203758
pubmed: 30192876
N Engl J Med. 2010 Jul 1;363(1):24-35
pubmed: 20530316
Future Oncol. 2011 Apr;7(4):481-4
pubmed: 21463135
Cancer. 2015 Oct 1;121(19):3455-64
pubmed: 26094818
J Clin Oncol. 2008 Jul 1;26(19):3138-46
pubmed: 18474879
Ann Oncol. 2020 Jun;31(6):745-759
pubmed: 33506766
BMC Cancer. 2016 Sep 23;16(1):749
pubmed: 27663357
Cancer Sci. 2020 Oct;111(10):3854-3861
pubmed: 32713038
Ann Oncol. 2017 Aug 01;28(8):1923-1933
pubmed: 28838214
Ann Oncol. 2018 Sep 1;29(9):1980-1986
pubmed: 30010779
Radiother Oncol. 2020 Oct;151:182-189
pubmed: 32687856
Head Neck. 2019 Aug;41(8):2676-2687
pubmed: 30903634
Oncotarget. 2017 Sep 27;8(54):92324-92332
pubmed: 29190918
Cancer Biomark. 2010-2011;8(2):95-107
pubmed: 21896997
Cancers (Basel). 2021 Feb 02;13(3):
pubmed: 33540527
Clin Cancer Res. 2004 Dec 15;10(24):8442-50
pubmed: 15623624
Mol Cell Proteomics. 2013 May;12(5):1306-18
pubmed: 23397110
Radiat Res. 2017 Jul;188(1):75-81
pubmed: 28504589
Oncol Rep. 2017 Aug;38(2):1268-1275
pubmed: 28677748
Proc Natl Acad Sci U S A. 2018 May 29;115(22):E5115-E5124
pubmed: 29760067
JCO Precis Oncol. 2019;3:
pubmed: 31485558
Expert Rev Mol Diagn. 2019 Dec;19(12):1109-1115
pubmed: 31680565
J Exp Clin Cancer Res. 2021 Jan 21;40(1):35
pubmed: 33478586
Cancer Biol Ther. 2020;21(2):139-146
pubmed: 31698994
Clin Cancer Res. 2004 Dec 15;10(24):8512-5
pubmed: 15623632
Clin Adv Hematol Oncol. 2010 Oct;8(10):680-2
pubmed: 21317864
Head Neck. 2019 May;41(5):1351-1358
pubmed: 30554450
J Pers Med. 2020 Nov 13;10(4):
pubmed: 33203021
Head Neck. 2019 Feb;41(2):291-300
pubmed: 30548891
Biol Chem. 2019 Oct 25;400(11):1465-1479
pubmed: 30903749
Acta Oncol. 2020 Jul;59(7):845-850
pubmed: 32223478
Int J Mol Sci. 2018 Mar 07;19(3):
pubmed: 29518940
Biomark Med. 2020 Oct;14(14):1393-1404
pubmed: 33073579
Clin Cancer Res. 2000 Nov;6(11):4171-5
pubmed: 11106228
Clin Cancer Res. 2014 Jan 15;20(2):425-33
pubmed: 24218516
Anal Cell Pathol (Amst). 2014;2014:450629
pubmed: 25763326
J Clin Oncol. 2009 Apr 20;27(12):1992-8
pubmed: 19289615
Clin Chem. 2017 Jul;63(7):1288-1296
pubmed: 28515105
Clin Cancer Res. 2008 Oct 1;14(19):6246-52
pubmed: 18829504
PLoS One. 2015 Jul 07;10(7):e0132669
pubmed: 26151639
PLoS One. 2020 Mar 24;15(3):e0221779
pubmed: 32208417
Oncol Rep. 2020 May;43(5):1525-1535
pubmed: 32323844
Nat Clin Pract Oncol. 2007 Feb;4(2):86-100
pubmed: 17259930
Viruses. 2019 Oct 09;11(10):
pubmed: 31600915
Oncoimmunology. 2019 Apr 24;8(7):1593805
pubmed: 31143513
J Clin Oncol. 2020 Apr 1;38(10):1050-1058
pubmed: 32017652
Sci Transl Med. 2015 Jun 24;7(293):293ra104
pubmed: 26109104
Br J Cancer. 2011 Apr 12;104(8):1319-24
pubmed: 21427725
J Clin Oncol. 2006 Apr 10;24(11):1754-60
pubmed: 16505414
Cancer Prev Res (Phila). 2010 Sep;3(9):1205-11
pubmed: 20660573
Anal Chim Acta. 2010 Nov 29;681(1-2):41-8
pubmed: 21035601
Eur J Cancer. 2012 Nov;48(16):3019-26
pubmed: 22682019
Sci Rep. 2020 Dec 9;10(1):21573
pubmed: 33299117
Clin Chem. 2018 Jun;64(6):959-970
pubmed: 29661793
Head Neck. 2020 Nov;42(11):3307-3315
pubmed: 32687251
PLoS One. 2014 Aug 08;9(8):e103918
pubmed: 25105871
Ann Oncol. 2016 May;27(5):908-13
pubmed: 26884588
Indian J Cancer. 2004 Jan-Mar;41(1):25-31
pubmed: 15105576
Int J Oral Maxillofac Surg. 2022 Mar;51(3):289-299
pubmed: 34154876
Theranostics. 2017 Jan 26;7(3):789-804
pubmed: 28255367
Oncologist. 2021 Jan;26(1):40-48
pubmed: 32864799
Curr Cancer Drug Targets. 2006 Dec;6(8):691-710
pubmed: 17168674
Epigenetics. 2012 Mar;7(3):291-9
pubmed: 22430805
Int J Cancer. 2005 Nov 20;117(4):605-10
pubmed: 15929076
Science. 2000 Mar 17;287(5460):2017-9
pubmed: 10720328
Oral Oncol. 2017 Dec;75:6-7
pubmed: 29224824
Cancer Control. 2020 Jul-Aug;27(3):1073274820944286
pubmed: 32726136
Am J Clin Pathol. 2014 Jun;141(6):796-804
pubmed: 24838323
BMC Cancer. 2019 Apr 23;19(1):373
pubmed: 31014274
Front Oncol. 2020 Mar 31;10:408
pubmed: 32296641
Clin Cancer Res. 2005 Apr 1;11(7):2486-91
pubmed: 15814624
Tumour Biol. 2017 Oct;39(10):1010428317736643
pubmed: 29072129
Sci Rep. 2016 Feb 02;6:20210
pubmed: 26831813
N Engl J Med. 2006 Feb 9;354(6):567-78
pubmed: 16467544
Cancer. 2013 May 15;119(10):1838-44
pubmed: 23436393
Clin Chem. 2019 Oct;65(10):1267-1275
pubmed: 31387885
Int J Cancer. 2020 Aug 15;147(4):1222-1227
pubmed: 31756275
Onco Targets Ther. 2017 Aug 04;10:3907-3916
pubmed: 28831265